Abstract:Osteoclasts, macrophages and dendritic cells (DCs) can be derived from a common trilineage myeloid progenitor of hematopoietic origin. Progenitor commitment is susceptible to regulation through Notch signaling. Our aim was to determine the effects of Notch modulation on trilineage progenitor commitment and functional properties of differentiated cells under inflammatory conditions. We used the conditional inducible CX3CR1CreERT2 mouse strain to achieve overexpression of the Notch 1 intracellular domain (NICD1) or to inhibit Notch signaling via deletion of the transcription factor RBP-J in a bone marrow population, used as a source of the trilineage progenitor (CD45+Ly6G-CD3-B220-NK1.1-CD11b-/loCD115+). Cre-recombinase, under the control of the CX3CR1 promoter, expressed in the monocyte/macrophage lineage, was induced in vitro by 4-hydroxytamoxifen. Differentiation of osteoclasts was induced by M-CSF/RANKL; macrophages by M-CSF; DCs by IL-4/GM-CSF, and inflammation by LPS. Functionally, DCs were tested for the ability to process and present antigen, macrophages to phagocytose E. coli particles, and osteoclasts to resorb bone and express tartrate-resistant acid phosphatase (TRAP). We found that Notch 1 signal activation suppressed osteoclast formation, whereas disruption of the Notch canonical pathway enhanced osteoclastogenesis, resulting in a higher number and size of osteoclasts. RANK protein and Ctsk gene expression were upregulated in osteoclastogenic cultures from RBP-J+ mice, with the opposing results in NICD1+ mice. Notch modulation did not affect the number of in vitro differentiated macrophages and DCs. However, RBP-J deletion stimulated Il12b and Cd86 expression in macrophages and DCs, respectively. Functional assays under inflammatory conditions confirmed that Notch silencing amplifies TRAP expression by osteoclasts, whereas the enhanced phagocytosis by macrophages was observed in both NICD1+ and RBP-J+ strains. Finally, antigen presentation by LPS-stimulated DCs was significantly downregulated with NICD1 overexpression. This experimental setting allowed us to define a cell-autonomous response to Notch signaling at the trilineage progenitor stage. Although Notch signaling modulation affected the activity of all three lineages, the major effect was observed in osteoclasts, resulting in enhanced differentiation and function with inhibition of canonical Notch signaling. Our results indicate that Notch signaling participates as the negative regulator of osteoclast activity during inflammation, which may be relevant in immune and bone diseases.

Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING‐Mediated Interferon‐β Signaling

Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1.

The STING Inhibitor C-176 Attenuates Osteoclast-Related Osteolytic Diseases by Inhibiting Osteoclast Differentiation

Molecular Mechanisms of Curdlan‐Induced Suppression of NFATc1 Expression in Osteoclasts

Deacylcynaropicrin Inhibits RANKL-Induced Osteoclastogenesis by Inhibiting NF-κB and MAPK and Promoting M2 Polarization of Macrophages.

Cpg Oligonucleotides: Novel Regulators Of Osteoclast Differentiation

Targeting STING: From antiviral immunity to treat osteoporosis

DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling

Signaling crosstalk between RANKL and interferons in osteoclast differentiation

CPG OLIGONUCLEOTIDES REGULATE OSTEOCLAST DIFFERENTIATION

Ca2+/CaM/CaMK signaling is involved in cadmium-induced osteoclast differentiation

The CD163/TWEAK/Fn14 axis: A potential therapeutic target for alleviating inflammatory bone loss

Osteoclast differentiation factors and their signaling pathways

Inhibition of Notch Signaling Stimulates Osteoclastogenesis From the Common Trilineage Progenitor Under Inflammatory Conditions

CpG Oligodeoxynucleotides Inhibit the Proliferation and Osteoclastic Differentiation of RAW264.7 Cells

Osteogenic CpG oligodeoxynucleotide, iSN40, inhibits osteoclastogenesis in a TLR9-dependent manner

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis Through Inhibition of MAPKs and NF-κB

Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling.

CpG Oligodeoxynucleotides Modulate the Osteoclastogenic Activity of Osteoblasts Via Toll-like Receptor 9*

S6K/FLNC/ITGβ3 Signaling Pathway Regulates Osteoclastogenesis and the Inhibition of Osteoclastogenesis by Columbianadin

IFN-β mediates the anti-osteoclastic effect of bisphosphonates and dexamethasone